TrialJAMA network open2022

Effect of Early High-Dose Recombinant Human Erythropoietin on Behavior and Quality of Life in Children Aged 5 Years Born Very Preterm: Secondary Analysis of a Randomized Clinical Trial.

Eleonora Picotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.